AIM IMMUNOTECH INC. Line of Credit Facility, Increase, Accrued Interest
AIM IMMUNOTECH INC. (AIM) reported Line of Credit Facility, Increase, Accrued Interest of $130.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityIncreaseAccruedInterest · last filed 2014-11-07
- AIM IMMUNOTECH INC. line of credit facility, increase, accrued interest for the quarter ending 2014-03-31 was $130.00K, a 188.89% increase year-over-year.
- AIM IMMUNOTECH INC. line of credit facility, increase, accrued interest for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. line of credit facility, increase, accrued interest for the quarter ending 2013-09-30 was $40.00K, a 42.86% increase year-over-year.
- AIM IMMUNOTECH INC. line of credit facility, increase, accrued interest for the quarter ending 2013-06-30 was $45.00K.
- AIM IMMUNOTECH INC. line of credit facility, increase, accrued interest for fiscal 2012 was $85.00K.
| Period end | Line of Credit Facility, Increase, Accrued Interest 3 month | Line of Credit Facility, Increase, Accrued Interest 6 month | Line of Credit Facility, Increase, Accrued Interest 9 month | Line of Credit Facility, Increase, Accrued Interest 12 month | Line of Credit Facility, Increase, Accrued Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2014-03-31 | $130.00K 10-Q · filed 2014-05-09 | $130.00K derived: sum of 2 quarters · filed 2014-11-07 | $170.00K derived: sum of 3 quarters · filed 2014-11-07 | $215.00K derived: sum of 4 quarters · filed 2014-11-07 | |
| 2013-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2014-11-07 | $40.00K derived: sum of 2 quarters · filed 2014-11-07 | $85.00K derived: sum of 3 quarters · filed 2014-11-07 | $130.00K 10-Q · filed 2014-11-07 | $143.00K 10-K · filed 2014-03-14 |
| 2013-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $85.00K derived: sum of 2 quarters · filed 2013-11-08 | $130.00K 10-Q · filed 2013-11-08 | $215.00K derived: sum of 4 quarters · filed 2014-03-14 | |
| 2013-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $90.00K 10-Q · filed 2013-08-09 | $175.00K derived: sum of 3 quarters · filed 2014-03-14 | $203.00K derived: sum of 4 quarters · filed 2014-03-14 | |
| 2013-03-31 | $45.00K 10-Q · filed 2013-05-08 | $130.00K derived: sum of 2 quarters · filed 2014-03-14 | $158.00K derived: sum of 3 quarters · filed 2014-03-14 | ||
| 2012-12-31 | $85.00K 10-K · filed 2014-03-14 | $113.00K derived: sum of 2 quarters · filed 2014-03-14 | $85.00K 10-K · filed 2013-03-18 | ||
| 2012-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $49.00K 10-Q · filed 2012-11-02 | |||
| 2012-06-30 | $21.00K 10-Q · filed 2012-08-08 | ||||
| 2011-12-31 | $6.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |